Eric Schlorff is the CEO of SeaStar Medical Holding Corp, a healthcare company that develops therapies for critically ill patients experiencing organ failure.
Eric Schlorff is the CEO of SeaStar Medical Holding Corp, a healthcare company that develops therapies for critically ill patients experiencing organ failure. He is responsible for the company's commercial-stage efforts, including a randomized controlled study for acute kidney injury in adults. Schlorff has identified the adult market opportunity as significantly larger than the pediatric segment.
Full founder directory · Investor directory · Company funding database · Fundraising library